This site uses cookies to ensure the best viewing experience for our readers.
Heart Care 3D Visualization Startup CathWorks Gets FDA Approval

Brief

Heart Care 3D Visualization Startup CathWorks Gets FDA Approval

The company's device enables physicians to visualize oxygen delivery to the heart in real-time using a specialized X-ray test

CTech  :  2018-12-26T16:46:26..
Israel-based CathWorks Ltd. has received approval from the U.S. Food and Drug Administration for its cardio 3D visualization system, the company announced last week. The non-invasive device, which already had a European CE Mark, enables physicians and clinicians to visualize oxygen delivery to the heart in real-time 3D using a specialized X-ray test. CathWorks raised a $15.8 million series B round in October 2017.

Medical procedure. Photo: Shutterstock Medical procedure. Photo: Shutterstock Medical procedure. Photo: Shutterstock

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS